Cowen & Co Starts Stock Coverage on XOMA Ltd (XOMA)

By admin | 6 years ago

Investment analysts at Cowen & Co began coverage on shares of XOMA Ltd (NASDAQ: XOMA) in a note issued to investors on Monday. The firm set an “outperform” rating on the stock.

XOMA Ltd opened at 2.59 on Monday. XOMA Ltd has a 1-year low of $1.04 and a 1-year high of $3.15. The company’s market cap is $176.3 million.

Separately, analysts at Ladenburg Thalmann cut their price target on shares of XOMA Ltd from $9.00 to $4.50 in a research note to investors on Tuesday, March 20th. They now have a “buy” rating on the stock.

XOMA Ltd. (XOMA) is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases.

About the author